Dalbavancin

Category: Antibiotics



Dalbavancin Overview

Dalbavancin (INN, trade names Dalvance in the US and Xydalba in Europe) is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin, the most widely used and one of the few treatments available to patients infected with methicillin-resistant Staphylococcus aureus (MRSA).[1] Dalbavancin is a semisynthetic lipoglycopeptide that was designed to improve upon the natural glycopeptides currently available, vancomycin and teicoplanin.[2] It possesses in vitro...

Read more Dalbavancin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dalbavancin

Recent Dalbavancin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dalbavancin
  • Injection: 500mg/vial
  • Powder: 500mg/vial
  • Powder, Lyophilized: 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Dalbavancin: (1 result)

Sorted by National Drug Code
  • 57970-100 Dalvance 500 mg/25ml Intravenous Injection, Powder, for Solution by Durata Therapeutics Inc.

Other drugs which contain Dalbavancin or a similar ingredient: (1 result)





Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. Site content is Copyright © 2005-2017 MedsChat.com and is protected under U.S. and International Copyright laws. All Rights Reserved. This page was last updated on 19 August 2017.

We are committed to your privacy.

Copyright © 2005-2017 All Rights Reserved. MedsChat® and The People's Medicine Community® are registered trademarks of Limelight Innovations L.L.C.